Palvella Therapeutics, Inc.
PVLA
$23.98
-$0.45-1.84%
| Weiss Ratings | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | D- | |||
| Rating Factors | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Good | |||
| Beta / Standard Deviation | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -14.14% | |||
| 30-Day Total Return | 24.77% | |||
| 60-Day Total Return | 62.80% | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | 99.83% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -16.54% | |||
| 52-Week Low % Change | 118.71% | |||
| Price | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $29.27 | |||
| 52-Week Low Price | $11.17 | |||
| 52-Week Low Price (Date) | Dec 30, 2024 | |||
| 52-Week High Price (Date) | Mar 13, 2025 | |||
| Valuation | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 274.14M | |||
| Enterprise Value | 190.53M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.60 | |||
| Earnings Per Share Growth | 1,087.59% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -1.60 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $23.98 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -18.49 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 5.72M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 484 253 1461 | |||
| Address | 125 Strafford Avenue Wayne, PA 19087 | |||
| Website | palvellatx.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -139.23% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -130.32% | |||
| Balance Sheet | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 14.21M | |||
| Cash Per Share (Q) | $2.48 | |||
| Total Current Assets (Q) | 16.32M | |||
| Total Preferred Equity (Q) | 70.60 | |||
| Total Equity (Q) | -16.80M | |||
| Current Ratio (Q) | 2.138 | |||
| Book Value Per Share (Q) | -$15.28 | |||
| Total Assets (Q) | 16.32M | |||
| Total Current Liabilities (Q) | 7.64M | |||
| Total Debt (Q) | 24.07M | |||
| Total Liabilities (Q) | 33.12M | |||
| Total Common Equity (Q) | -87.40M | |||
| Cash Flow | PVLA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
